$627 Million is the total value of First Light Asset Management, LLC's 59 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMCL | Sell | OMNICELL INC | $40,459,000 | -15.1% | 660,655 | -0.4% | 6.45% | -16.1% |
| ATRC | Sell | ATRICURE INC | $29,553,000 | -13.0% | 965,797 | -0.4% | 4.71% | -14.0% |
| SHPG | Sell | SHIRE PLC | $28,440,000 | -31.4% | 163,409 | -28.5% | 4.53% | -32.2% |
| NEO | Sell | NEOGENOMICS INC | $27,845,000 | -51.0% | 2,208,188 | -40.3% | 4.44% | -51.6% |
| HRTX | Sell | HERON THERAPEUTICS INC | $21,407,000 | -18.8% | 825,269 | -0.9% | 3.41% | -19.8% |
| XNCR | Sell | XENCOR INC | $16,842,000 | -7.6% | 465,770 | -0.4% | 2.68% | -8.7% |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $13,735,000 | -27.6% | 482,104 | -0.5% | 2.19% | -28.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $5,266,000 | -12.8% | 61,839 | -0.7% | 0.84% | -13.8% |
| LHCG | Sell | LHC GROUP INC | $5,031,000 | -9.4% | 53,587 | -0.7% | 0.80% | -10.5% |
| GMED | Sell | GLOBUS MEDICAL INC | $4,467,000 | -24.3% | 103,217 | -0.7% | 0.71% | -25.2% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $4,269,000 | -5.5% | 122,394 | -0.7% | 0.68% | -6.6% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $4,079,000 | -14.6% | 24,615 | -0.7% | 0.65% | -15.7% |
| TECH | Sell | BIO TECHNE CORP | $3,625,000 | -29.6% | 25,048 | -0.7% | 0.58% | -30.4% |
| BLUE | Sell | BLUEBIRD BIO INC | $3,274,000 | -32.5% | 33,002 | -0.6% | 0.52% | -33.3% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $3,160,000 | -53.4% | 345,339 | -36.8% | 0.50% | -53.9% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $2,817,000 | -33.2% | 98,411 | -34.9% | 0.45% | -34.0% |
| QDEL | Sell | QUIDEL CORP | $2,661,000 | -25.6% | 54,511 | -0.7% | 0.42% | -26.5% |
| HSTM | Sell | HEALTHSTREAM INC | $2,179,000 | -22.8% | 90,210 | -0.9% | 0.35% | -23.7% |
| LMAT | Sell | LEMAITRE VASCULAR INC | $1,163,000 | -39.5% | 49,217 | -0.8% | 0.18% | -40.3% |
| CLLS | Sell | CELLECTIS SA | $437,000 | -79.7% | 26,234 | -65.6% | 0.07% | -79.9% |
| STRM | Exit | STREAMLINE HEALTH SOLUTIONS | $0 | – | -39,701 | -100.0% | -0.01% | – |
| HRC | Exit | HILL-ROM HOLDINGS INC | $0 | – | -2,144 | -100.0% | -0.03% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -1,513 | -100.0% | -0.03% | – |
| PKI | Exit | PERKINELMER INC | $0 | – | -2,270 | -100.0% | -0.04% | – |
| ENZ | Exit | ENZO BIOCHEM INC | $0 | – | -188,159 | -100.0% | -0.12% | – |
| RMED | Exit | RA Medical Systems, Inc. | $0 | – | -60,000 | -100.0% | -0.18% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INC | $0 | – | -265,877 | -100.0% | -0.73% | – |
| KTWO | Exit | K2M GROUP HOLDINGS INC | $0 | – | -289,756 | -100.0% | -1.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.